Jane Street’s Park Ha Biological Technology Co BYAH Stock Holding History

Jane Street’s Portfolio BYAH Stock Details BYAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-93	Closed	-$5.92K	–	13249
2025 Q4	$5.92K	Buy	+93	New	+$11.3K	﹤0.01%	10891
2025 Q3	–	Sell	-14	Closed	-$202K	–	11998
2025 Q2	$202K	Buy	+14	New	+$94.1K	﹤0.01%	8526
2025 Q1	–	Sell	-64	Closed	-$161K	–	10894
2024 Q4	$161K	Buy	+64	New	+$130K	﹤0.01%	8544

Other funds holding BYAH

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's BYAH Position: Q1 2026 in Review

Jane Street sold out of Park Ha Biological Technology Co (BYAH) in Q1 2026, closing a stake of 93 shares — an estimated $5.92K sold.

Jane Street first reported a position in BYAH in Q4 2024 and held it in 3 quarters. The position peaked at $202K in Q2 2025. 2 funds tracked by Wall St. Rank hold BYAH as of Q1 2026.

Jane Street reported no remaining Park Ha Biological Technology Co position as of Q1 2026 after selling out during the quarter.
Jane Street sold 93 Park Ha Biological Technology Co shares in Q1 2026, an estimated $5.92K.
Jane Street first reported a position in Park Ha Biological Technology Co in Q4 2024 and held it in 3 quarters.
Jane Street's Park Ha Biological Technology Co position peaked at $202K in Q2 2025.
2 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.